" class="no-js "lang="en-US"> UCB Archives - Medtech Alert
Monday, April 15, 2024

Sort by:

Date

Top Post

Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease

An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]

ClearPoint Neuro and UCB Enter License Agreement for Gene Therapy Drug Delivery

ClearPoint Neuro, a global therapy-enabling platform company providing navigation and delivery to the brain, today […]

UCB and Ariceum Therapeutics Sign a Strategic Research Collaboration to Discover New Modalities for the Treatment of Immune-related Diseases and Cancer

Ariceum Therapeutics (Ariceum), a private biotech company developing radiopharmaceutical products for the diagnosis and treatment […]

Huma and UCB to Provide Digital Health Solution for Myasthenia Gravis

Huma Therapeutics, a leading global digital health company, and UCB, a global biopharmaceutical company, are […]

Aitia and UCB Announce Strategic Drug Discovery Collaboration in Huntington's Disease

UCB, a global biopharmaceutical company, and Aitia, the leader in the application of Causal AI […]

Pheno Therapeutics Announces Worldwide License from UCB to a Novel Program for Neurodegenerative Disease

Pheno Therapeutics, a biotechnology company focused on the discovery and development of small molecule therapeutics […]

  1. Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
  2. Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
  3. DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
  4. Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
  5. Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more